Literature DB >> 3304476

Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.

J Harvey, N de Klerk, I Berryman, G Sterrett, M Byrne, J Papadimitriou.   

Abstract

Nuclear DNA content was measured by static cytophotometry in smears from breast carcinomas from 80 women, and the results were correlated with other prognostic variables and survival using multivariate statistical analysis. 49% of patients had diploid tumors and 51% hyperdiploid tumors. There was a strong correlation between DNA ploidy and axillary lymph node status, tumor size, ER status, and short term survival (median follow-up 40 months). Of all parameters measured, ploidy showed the strongest correlation with survival, and was a significant prognostic indicator even when other prognostic factors were taken into account.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304476     DOI: 10.1007/BF01807362

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  32 in total

1.  Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Authors:  S B Ewers; E Långström; B Baldetorp; D Killander
Journal:  Cytometry       Date:  1984-07

2.  3. The value of chromosome studies in the classification and management of the leukemias.

Authors:  O M Garson
Journal:  Pathology       Date:  1982-07       Impact factor: 5.306

3.  Nuclear feulgen DNA content and nuclear size in human breast carcinoma.

Authors:  S D Fosså; P F Marton; O S Knudsen; O Kaalhus; O Børmer; S Vaage
Journal:  Hum Pathol       Date:  1982-07       Impact factor: 3.466

4.  Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

Authors:  D W Hedley; C A Rugg; A B Ng; I W Taylor
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

5.  Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement.

Authors:  C J Cornelisse; H R de Koning; A J Moolenaar; C J van de Velde; J S Ploem
Journal:  Anal Quant Cytol       Date:  1984-03

6.  The influence of age on the DNA ploidy levels of breast tumours.

Authors:  I W Taylor; E A Musgrove; M L Friedlander; M S Foo; D W Hedley
Journal:  Eur J Cancer Clin Oncol       Date:  1983-05

7.  Prolymphocytic leukemia: flow microfluorometric, immunologic, and cytogenetic observations.

Authors:  L W Diamond; R M Bearman; P K Berry; B J Mills; B N Nathwani; D D Weisenburger; C D Winberg; R L Teplitz; H Rappaport
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047

8.  DNA flow cytometry in primary breast carcinoma.

Authors:  S D Fosså; E Thorud; M C Shoaib; E O Pettersen; J Høie; O S Knudsen
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1984-11

9.  Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.

Authors:  T E Kute; H B Muss; D Anderson; K Crumb; B Miller; D Burns; L A Dube
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

10.  Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer.

Authors:  D J Horsfall; W D Tilley; S R Orell; V R Marshall; E L Cant
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

View more
  5 in total

1.  Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: correlation and relative prognostic influence.

Authors:  T Hatschek; O Gröntoft; G Fagerberg; O Stål; S Sullivan; J Carstensen; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

2.  The prognostic value of tumor-associated carbohydrate structures correlated with gene amplifications in human breast carcinomas.

Authors:  T Fukutomi; S Hirohashi; H Tsuda; T Nanasawa; H Yamamoto; M Itabashi; Y Shimosato
Journal:  Jpn J Surg       Date:  1991-09

3.  Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.

Authors:  S B Ewers; R Attewell; B Baldetorp; A Borg; E Långström; D Killander
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

4.  Nuclear characteristics as indicators of prognosis in node negative breast cancer patients.

Authors:  V le Doussal; M Tubiana-Hulin; K Hacene; S Friedman; M Brunet
Journal:  Breast Cancer Res Treat       Date:  1989-11       Impact factor: 4.872

5.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.